Continuous Peripheral Nerve Block Catheter Market Analysis & Forecast: 2026-2033
Continuous peripheral nerve block catheter market is estimated to be valued at USD 681.9 Mn in 2026 and is expected to reach USD 1038.0 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 6.2% from 2026 to 2033.
The global continuous peripheral nerve block catheter market is expected to witness rapid growth due to the increasing number of surgical procedures, especially in the field of orthopedic surgery and trauma, as well as the growing emphasis on effective postoperative pain management for improved patient outcomes.
With the global healthcare systems emphasizing the need for opioid-sparing pain management strategies, the use of continuous peripheral nerve block catheters is gaining popularity for upper and lower extremity surgeries and chronic pain syndromes. The growing geriatric population and the increasing incidence of chronic conditions such as osteoarthritis are also contributing to the rising demand for continuous peripheral nerve block catheters.
|
Current Events |
Description and its impact |
|
China's Medical Device Regulatory Harmonization and Market Access Reforms |
|
|
Supply Chain Disruptions and Raw Material Inflation |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Based on product type, the Non-Stimulating Catheter segment is projected to account for the largest market share of 56% in 2026. This can be attributed to the widespread use of non-stimulating catheters in hospitals and surgical centers. Non-stimulating catheters are preferred owing to the ease of placement, which is less expensive and reliable for continuous regional analgesia. The market is also driven by recommendations from clinical guidelines for safe and effective pain management.
For instance, in January 2025, B. Braun Medical Inc. unveiled new Clik FIX Epidural/PNB Catheter Securement Device, which is a product that aims to improve the securement of peripheral nerve block catheters, including non-stimulating catheters, and prevent dislodgement during regional anesthesia procedures. procedures.
In terms of insertion technique, the Ultrasound Guided segment is expected to register a market share of 50% in 2026. This is because ultrasound guidance is associated with accurate catheter positioning, lower complication rates, and more effective analgesia than the conventional approach. This is why hospitals and ambulatory surgical centers are adopting ultrasound-guided procedures.
For instance, in August 2025, SmartAlpha’s AI-assisted ultrasound solution, Nerveblox, received clearance from the U.S. Food and Drug Administration (510(k)) to help doctors identify important anatomical structures during ultrasound-guided regional anesthesia procedures.
By indication, the Lower Extremity Surgeries segment is anticipated to account for 37% of the total market share in 2026, due to the large number of procedures performed during orthopedic surgeries like knee and hip replacements. Continuous peripheral nerve block catheters are the preferred choice for such surgeries because they help in pain relief.
For instance, in January 2026, Teleflex launched its FlexBlock Pro Continuous Peripheral Nerve Block Catheter. This improved version comes with an ultrasound-guided echogenic tip that is intended to provide better accuracy during lower extremity orthopedic surgeries like total knee and shoulder arthroplasties.
Based on end user, the Hospitals segment is anticipated to lead with a 63% market share in 2026. Hospitals continue to be the main source of revenue because of the large number of patients, complex surgeries, and well-established anesthesia departments. Ambulatory surgical centers are also turning to these catheters, but the hospital segment leads because of the larger procedural volume and the availability of trained anesthesiologists.
For instance, in December 2025, ICU Medical launched its NexGen Continuous Peripheral Nerve Block (CPNB) system, which featured integrated pressure sensors and antimicrobial coatings, and was approved for Medicare Part B reimbursement in U.S. hospitals and ambulatory surgical centers.
To learn more about this report, Download Free Sample
North America is projected to lead the market for continuous peripheral nerve block catheters in 2026, with a market share of 45%. The growth of the market in the North American region can be attributed to factors such as the high number of surgical procedures, well-developed healthcare infrastructure, increasing awareness of opioid-sparing pain management practices, and adoption of technologically advanced catheter systems in healthcare settings..
For instance, in November 2025, Pajunk Medical launched its SonoBlock Ultra continuous peripheral nerve block catheter in the U.S., featuring an integrated nerve stimulation backup to support accurate placement in Level 1 trauma centers and hospital pain management units
The Asia Pacific market is expected to be the fastest-growing market for continuous peripheral nerve block catheters because of the growing healthcare expenditure, number of hospitals and surgical centers, and awareness about postoperative pain management, along with the adoption of advanced catheter technology. New entrants from emerging countries and abroad are offering cost-effective and proven catheter solutions to hospitals in developing countries.
For instance, in October 2025, ACE Medical Japan launched the NanoCath ambulatory pump‑catheter combo, which was approved for home discharge use after anterior cruciate ligament (ACL) reconstruction surgeries.
The continuous peripheral nerve block catheter market in the U.S. is growing at a fast pace due to the large number of surgeries being performed, the advanced infrastructure of hospitals, and the adoption of opioid-sparing pain management solutions. Hospitals and ambulatory surgery centers are adopting technologically advanced catheters, such as ultrasound-guided catheters.
For instance, in January 2026, Teleflex introduced its FlexBlock Pro continuous peripheral nerve block catheter in the United States. This device features an ultrasound‑guided echogenic tip to enhance placement accuracy for orthopedic procedures such as knee and shoulder arthroplasty, supports prolonged analgesia, and aims to reduce opioid usage in postoperative pain management.
China’s continuous peripheral nerve block catheter market is experiencing strong growth due to the increasing awareness of regional anesthesia, the growing capacity of hospitals, and the increasing use of ultrasound-guided techniques. There is a growing need for minimally invasive pain management techniques, which is fueling the strong growth of the catheter market.
For instance, in September 2025, Lucintel released its China Continuous Peripheral Nerve Block Catheter Market report, projecting strong market growth in China and emphasizing key trends such as increasing adoption of ultrasound‑guided insertion techniques.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 681.9 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.2% | 2033 Value Projection: | USD 1,038.0 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Teleflex Incorporated, Braun Melsungen AG, Lepu Medical Technology Co.,Ltd., Halyard Health, Inc., ACE Medical Devices Pvt. Ltd., Ambu A/S, Epimed International Inc., Avanos Medical, Inc., Epimed, Sarstedt, Pajunk GmbH., Bard Medical, IMEDICOM, Accura Medizintechnik, Henan Tuoren Medical Device, Vygon, Scilex Holding, and ICU Medical, Inc. |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
The increasing focus on enhanced recovery after surgery (ERAS) protocols and the need to reduce opioid consumption have driven hospitals and ambulatory surgical centers to adopt continuous peripheral nerve block catheters. These devices allow precise, targeted pain management, improving patient outcomes and reducing hospital stays, which is fueling market growth in North America, China, and other key regions.
The market presents opportunities through the launch of ultrasound-guided, echogenic, and antimicrobial catheter systems. Companies can also develop ambulatory catheter systems for home-based pain management, expanding their reach beyond traditional hospital settings. Innovations such as integrated pressure sensors, nerve stimulation backup, and smart infusion pumps can attract hospitals, surgical centers, and outpatient facilities seeking safer and more efficient pain management solutions.
The continuous peripheral nerve block (CPNB) catheter market has evolved from a niche segment of regional anesthesia to a core element of modern postoperative pain management. Hospitals and ambulatory surgical centers increasingly rely on these systems because they provide more precise and consistent analgesia, improve patient mobility after surgery, and enhance overall recovery experiences.
Geographically, North America remains a leading adopter due to well-established hospital infrastructure and strong clinical acceptance, but Asia Pacific markets, especially China and Japan, are rapidly expanding. Hospitals in these regions are integrating advanced CPNB systems into enhanced recovery programs, reflecting a growing focus on improving surgical outcomes and reducing reliance on systemic pain medications.
Overall, the CPNB catheter market is shifting from a supplementary tool to an essential standard of care, driven by technological innovation, adoption of outpatient protocols, and the healthcare sector’s focus on optimizing recovery, patient comfort, and procedural safety. Companies that combine advanced catheter design, clinician training, and ambulatory solutions are poised to lead this transformation.
Share
Share
About Author
Komal Dighe is a Management Consultant with over 8 years of experience in market research and consulting. She excels in managing and delivering high-quality insights and solutions in Health-tech Consulting reports. Her expertise encompasses conducting both primary and secondary research, effectively addressing client requirements, and excelling in market estimation and forecast. Her comprehensive approach ensures that clients receive thorough and accurate analyses, enabling them to make informed decisions and capitalize on market opportunities.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
Schedule a meeting with report Author
